| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | Common Stock | 3.96K | $535K | $134.98 | 21 May 2025 | Direct |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | Stock Options (Right to Buy) | 2.08K | $280K | $134.98 | 21 May 2025 | Direct |
| Maze Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 18K | 22 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 22 Sep 2025 | 1 | $0 | 4 | Director | 24 Sep 2025, 16:13 |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 21 May 2025 | 2 | $408K | 4 | Director | 23 May 2025, 16:08 |
| MAZE | Maze Therapeutics, Inc. | 30 Jan 2025 | 0 | $0 | 3 | Director | 30 Jan 2025, 16:25 |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 13 May 2024 | 2 | $427K | 4 | Director | 15 May 2024, 19:24 |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 15 May 2023 | 2 | $321K | 4 | Director | 17 May 2023, 14:11 |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 11 May 2022 | 2 | $352K | 4 | Director | 13 May 2022, 16:03 |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 07 May 2021 | 2 | $0 | 4 | Director | 10 May 2021, 17:16 |